{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:00:18Z","timestamp":1792501218124,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10815-021-02179-0","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:09:21Z","timestamp":1617923361000},"page":"1787-1797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["FSH dose is negatively correlated with number of oocytes retrieved: analysis of a data set with ~650,000 ART cycles that previously identified an inverse relationship between FSH dose and live birth rate"],"prefix":"10.1007","volume":"38","author":[{"given":"Zaramasina L.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mili","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-8000","authenticated-orcid":false,"given":"James J.","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"2179_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fertnstert.2016.09.044","volume":"107","author":"N Pereira","year":"2017","unstructured":"Pereira N, Friedman C, Hutchinson AP, Lekovich JP, Elias RT, Rosenwaks Z. Increased odds of live birth in fresh in vitro fertilization cycles with shorter ovarian stimulation. Fertil Steril. 2017;107:104\u2013109.e102.","journal-title":"Fertil Steril"},{"key":"2179_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0015-0282(16)58269-7","volume":"65","author":"JA Land","year":"1996","unstructured":"Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril. 1996;65:961\u20135.","journal-title":"Fertil Steril"},{"key":"2179_CR3","doi-asserted-by":"crossref","unstructured":"Leijdekkers JA, Torrance HL, Schouten NE, van Tilborg TC, Oudshoorn SC, Mol BWJ, et al. Individualized ovarian stimulation in IVF\/ICSI treatment: it is time to stop using high FSH doses in predicted low responders. Hum Reprod. 2020;35:1954\u201363.","DOI":"10.1093\/humrep\/dez184"},{"key":"2179_CR4","first-page":"CD012693","volume":"2","author":"SF Lensen","year":"2018","unstructured":"Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI). Cochrane Database Syst Rev. 2018;2:CD012693.","journal-title":"Cochrane Database Syst Rev"},{"key":"2179_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","volume":"104","author":"VL Baker","year":"2015","unstructured":"Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 2015;104:1145\u20131152.e1145.","journal-title":"Fertil Steril"},{"key":"2179_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1472-6483(10)60256-8","volume":"18","author":"F Olivennes","year":"2009","unstructured":"Olivennes F, Howles CM, Borini A, Germond M, Trew G, Wikland M, et al. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod BioMed Online. 2009;18:195\u2013204.","journal-title":"Reprod BioMed Online"},{"key":"2179_CR7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","volume":"102","author":"J-C Arce","year":"2014","unstructured":"Arce J-C, Nyboe Andersen A, Fern\u00e1ndez-S\u00e1nchez M, Visnova H, Bosch E, Garc\u00eda-Velasco JA, et al. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone\u2013stratified, dose\u2013response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2014;102:1633\u20131640.e1635.","journal-title":"Fertil Steril"},{"key":"2179_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","volume":"94","author":"M Berkkanoglu","year":"2010","unstructured":"Berkkanoglu M, Ozgur K. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil Steril. 2010;94:662\u20135.","journal-title":"Fertil Steril"},{"key":"2179_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/09513590.2016.1199018","volume":"32","author":"S Friedler","year":"2016","unstructured":"Friedler S, Meltzer S, Saar-Ryss B, Rabinson J, Lazer T, Liberty G. An upper limit of gonadotropin dose in patients undergoing ART should be advocated. Gynecol Endocrinol. 2016;32:965\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"2179_CR10","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.fertnstert.2007.05.055","volume":"89","author":"L Pal","year":"2008","unstructured":"Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694\u2013701.","journal-title":"Fertil Steril"},{"key":"2179_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0015-0282(16)56756-9","volume":"61","author":"L Stadtmauer","year":"1994","unstructured":"Stadtmauer L, Ditkoff EC, Session D, Kelly A. High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer. Fertil Steril. 1994;61:1058\u201364.","journal-title":"Fertil Steril"},{"key":"2179_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/humrep\/16.6.1104","volume":"16","author":"HJ Out","year":"2001","unstructured":"Out HJ, David I, Ron-El R, Friedler S, Shalev E, Geslevich J, et al. A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum Reprod. 2001;16:1104\u20139.","journal-title":"Hum Reprod"},{"key":"2179_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/humrep\/15.1.29","volume":"15","author":"HJ Out","year":"2000","unstructured":"Out HJ, Braat DDM, Lintsen BME, Gurgan T, Bukulmez O, G\u00f6kmen O, et al. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon\u00ae) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod. 2000;15:29\u201335.","journal-title":"Hum Reprod"},{"key":"2179_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/humrep\/deh663","volume":"20","author":"ER Klinkert","year":"2005","unstructured":"Klinkert ER, Broekmans FJM, Looman CWN, Habbema JDF, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod. 2005;20:611\u20135.","journal-title":"Hum Reprod"},{"key":"2179_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10815-005-1497-1","volume":"22","author":"SL Tan","year":"2005","unstructured":"Tan SL, Child TJ, Cheung AP, Fluker MR, Yuzpe A, Casper R, et al. A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon\u00ae) in women undergoing controlled ovarian hyperstimulation for ivf treatment. J Assist Reprod Genet. 2005;22:81\u20138.","journal-title":"J Assist Reprod Genet"},{"key":"2179_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","volume":"25","author":"DN Lekamge","year":"2008","unstructured":"Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet. 2008;25:515\u201321.","journal-title":"J Assist Reprod Genet"},{"key":"2179_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/humupd\/dmq041","volume":"17","author":"MD Sterrenburg","year":"2011","unstructured":"Sterrenburg MD, Veltman-Verhulst SM, Eijkemans MJC, Hughes EG, Macklon NS, Broekmans FJ, et al. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Hum Reprod Update. 2011;17:184\u201396.","journal-title":"Hum Reprod Update"},{"key":"2179_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","volume":"19","author":"SL Broer","year":"2013","unstructured":"Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26\u201336.","journal-title":"Hum Reprod Update"},{"key":"2179_CR19","first-page":"336","volume":"21","author":"E Borges Jr","year":"2017","unstructured":"Borges E Jr, Zanetti BF, Setti AS, Braga DPAF, Figueira RCS, Iaconelli A Jr. FSH dose to stimulate different patient' ages: when less is more. JBRA Assist Reprod. 2017;21:336\u201342.","journal-title":"JBRA Assist Reprod"},{"key":"2179_CR20","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/humrep\/dex318","volume":"32","author":"TC van Tilborg","year":"2017","unstructured":"van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, et al. Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 1: the predicted poor responder. Hum Reprod. 2017;32:2496\u2013505.","journal-title":"Hum Reprod"},{"key":"2179_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00404-018-4884-4","volume":"298","author":"Y Huang","year":"2018","unstructured":"Huang Y, Li J, Zhang F, Liu Y, Xu G, Guo J, et al. Factors affecting the live-birth rate in women with diminished ovarian reserve undergoing IVF-ET. Arch Gynecol Obstet. 2018;298:1017\u201327.","journal-title":"Arch Gynecol Obstet"},{"key":"2179_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/mrd.20128","volume":"69","author":"CMH Combelles","year":"2004","unstructured":"Combelles CMH, Carabatsos MJ, Kumar TR, Matzuk MM, Albertini DF. Hormonal control of somatic cell oocyte interactions during ovarian follicle development. Mol Reprod Dev. 2004;69:347\u201355.","journal-title":"Mol Reprod Dev"},{"key":"2179_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1095\/biolreprod.104.032003","volume":"72","author":"R Roberts","year":"2005","unstructured":"Roberts R, Iatropoulou A, Ciantar D, Stark J, Becker DL, Franks S, et al. Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro1. Biol Reprod. 2005;72:107\u201318.","journal-title":"Biol Reprod"},{"key":"2179_CR24","doi-asserted-by":"crossref","unstructured":"Karl KR, Jimenez-Krassel F, Gibbings E, Ireland JLH, Clark ZL, Tempelman RJ, et al. Negative impact of high doses of follicle-stimulating hormone during superovulation on the ovulatory follicle function in small ovarian reserve dairy heifers\u2020. Biol Reprod. 2021;104:695\u2013705.","DOI":"10.1093\/biolre\/ioaa210"},{"key":"2179_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2527\/jas1986.631176x","volume":"63","author":"SP Lerner","year":"1986","unstructured":"Lerner SP, Thayne WV, Baker RD, Henschen T, Meredith S, Inskeep EK, et al. Age, dose of FSH and other factors affecting superovulation in Holstein cows. J Anim Sci. 1986;63:176\u201383.","journal-title":"J Anim Sci"},{"key":"2179_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0093-691X(86)90059-2","volume":"25","author":"J Saumande","year":"1986","unstructured":"Saumande J, Chupin D. Induction of superovulation in cyclic heifers: the inhibitory effect of large doses of PMSG. Theriogenology. 1986;25:233\u201347.","journal-title":"Theriogenology"},{"key":"2179_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","volume":"13","author":"MH van der Gaast","year":"2006","unstructured":"van der Gaast MH, Eijkemans MJC, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, et al. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod BioMed Online. 2006;13:476\u201380.","journal-title":"Reprod BioMed Online"},{"key":"2179_CR28","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768\u201374.","journal-title":"Hum Reprod"},{"key":"2179_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/humrep\/des389","volume":"28","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod. 2013;28:442\u201352.","journal-title":"Hum Reprod"},{"key":"2179_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","volume":"110","author":"NP Polyzos","year":"2018","unstructured":"Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women. Fertil Steril. 2018;110:661\u2013670.e661.","journal-title":"Fertil Steril"},{"key":"2179_CR31","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of \u2018poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria\u2020. Hum Reprod. 2011;26:1616\u201324.","journal-title":"Hum Reprod"},{"key":"2179_CR32","doi-asserted-by":"crossref","unstructured":"Broekmans FJ. Individualization of FSH doses in assisted reproduction: facts and fiction. Frontiers in Endocrinology. 2019;10:181.","DOI":"10.3389\/fendo.2019.00181"},{"key":"2179_CR33","unstructured":"Prevention CfDCa, Medicine ASfR, Technology SfAR. 2012 Assisted reproductive technology national summary report. In: Atlanta: US Dept of Health and Human Services; 2014."},{"key":"2179_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1472-6483(10)60654-2","volume":"13","author":"JR Martin","year":"2006","unstructured":"Martin JR, Mahutte NG, Arici A, Sakkas D. Impact of duration and dose of gonadotrophins on IVF outcomes. Reprod BioMed Online. 2006;13:645\u201350.","journal-title":"Reprod BioMed Online"},{"key":"2179_CR35","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/humrep\/dex299","volume":"32","author":"OO Barash","year":"2017","unstructured":"Barash OO, Hinckley MD, Rosenbluth EM, Ivani KA, Weckstein LN. High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer. Hum Reprod. 2017;32:2209\u201317.","journal-title":"Hum Reprod"},{"key":"2179_CR36","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1093\/oxfordjournals.humrep.a135887","volume":"10","author":"A Shulman","year":"1995","unstructured":"Shulman A, Ghetler Y, Fejgin M, Kaneti H, Weinstein S, Beyth Y, et al. Relationship between the threshold of ovarian sensitivity to human menopausal gonadotrophin stimulation and in-vitro fertilization treatment outcome. Hum Reprod. 1995;10:3198\u2013201.","journal-title":"Hum Reprod"},{"key":"2179_CR37","doi-asserted-by":"crossref","unstructured":"Griesinger G, Dietrich B, St\u00f6ckl L, Eckert K, Goletz S, Tandler-Schneider A. Fully human glyco-optimized recombinant FSH (follitropin epsilon) \u2013 a randomized, comparator-controlled phase II clinical trial. Reproductive BioMedicine Online. 2020;40:331\u201341.","DOI":"10.1016\/j.rbmo.2019.09.003"},{"key":"2179_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF01139183","volume":"6","author":"GE Hofmann","year":"1989","unstructured":"Hofmann GE, Toner JP, Muasher SJ, Jones GS. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. J In Vitro Fert Embryo Transf. 1989;6:285\u20139.","journal-title":"J In Vitro Fert Embryo Transf"},{"key":"2179_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/BF02744936","volume":"15","author":"DL Hock","year":"1998","unstructured":"Hock DL, Louie H, Shelden RM, Ananth CV, Kemmann E. The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome. J Assist Reprod Genet. 1998;15:427\u201330.","journal-title":"J Assist Reprod Genet"},{"key":"2179_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmr037","volume":"18","author":"JF Oudendijk","year":"2012","unstructured":"Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL. The poor responder in IVF: is the prognosis always poor? A systematic review. Hum Reprod Update. 2012;18:1\u201311.","journal-title":"Hum Reprod Update"},{"key":"2179_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0015-0282(02)04583-1","volume":"79","author":"PYK Yong","year":"2003","unstructured":"Yong PYK, Brett S, Baird DT, Thong KJ. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril. 2003;79:308\u201315.","journal-title":"Fertil Steril"},{"key":"2179_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","volume":"15","author":"Q Chen","year":"2017","unstructured":"Chen Q, Wang Y, Sun L, Zhang S, Chai W, Hong Q, et al. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol. 2017;15:71.","journal-title":"Reprod Biol Endocrinol"},{"key":"2179_CR43","doi-asserted-by":"publisher","first-page":"e023124","DOI":"10.1136\/bmjopen-2018-023124","volume":"8","author":"VA Kushnir","year":"2018","unstructured":"Kushnir VA, Darmon SK, Barad DH, Gleicher N. Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation. BMJ Open. 2018;8:e023124.","journal-title":"BMJ Open"},{"key":"2179_CR44","doi-asserted-by":"crossref","unstructured":"Johnson GP, Jonas KC. Mechanistic insight into how gonadotropin hormone receptor complexes direct signaling. Biol Reprod. 2020;102:773\u201383.","DOI":"10.1093\/biolre\/ioz228"},{"key":"2179_CR45","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","volume":"80","author":"E Bosch","year":"2003","unstructured":"Bosch E, Valencia I, Escudero E, Crespo J, Sim\u00f3n C, Remoh\u00ed J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80:1444\u20139.","journal-title":"Fertil Steril"},{"key":"2179_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0015-0282(16)58453-2","volume":"66","author":"F Ubaldi","year":"1996","unstructured":"Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril. 1996;66:275\u201380.","journal-title":"Fertil Steril"},{"key":"2179_CR47","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1210\/endo.133.6.8243314","volume":"133","author":"JS Tapanainen","year":"1993","unstructured":"Tapanainen JS, Lapolt PS, Perlas E, Hsueh AJ. Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone. Endocrinology. 1993;133:2875\u201380.","journal-title":"Endocrinology"},{"key":"2179_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0015-0282(16)54186-7","volume":"55","author":"W Schoolcraft","year":"1991","unstructured":"Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991;55:563\u20136.","journal-title":"Fertil Steril"},{"key":"2179_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0015-0282(16)49220-4","volume":"45","author":"B Lejeune","year":"1986","unstructured":"Lejeune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration *. Fertil Steril. 1986;45:377\u201383.","journal-title":"Fertil Steril"},{"key":"2179_CR50","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1210\/me.2005-0462","volume":"20","author":"SA Pangas","year":"2006","unstructured":"Pangas SA, Li X, Robertson EJ, Matzuk MM. Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol Endocrinol. 2006;20:1406\u201322.","journal-title":"Mol Endocrinol"},{"key":"2179_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0015-0282(16)56221-9","volume":"60","author":"GE Hofmann","year":"1993","unstructured":"Hofmann GE, Bentzien F, Bergh PA, John Garrisi G, Williams MC, Guzman I, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60:675\u20139.","journal-title":"Fertil Steril"},{"key":"2179_CR52","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/humrep\/dex094","volume":"32","author":"EM Munch","year":"2017","unstructured":"Munch EM, Sparks AE, Zimmerman MB, Van Voorhis BJ, Duran EH. High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers. Hum Reprod. 2017;32:1402\u20139.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-021-02179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-021-02179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-021-02179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T07:23:57Z","timestamp":1675149837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-021-02179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1007\/s10815-021-02179-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was previously approved by the Institutional Review Board at Michigan State University [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}